ID   Tera-2_CDDP
AC   CVCL_XI45
DR   Wikidata; Q98133220
RX   PubMed=31500094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2777 ! Tera-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
RX   PubMed=31500094; DOI=10.3390/cancers11091316; PMCID=PMC6769617;
RA   Bakardjieva-Mihaylova V., Skvarova Kramarzova K., Slamova M.,
RA   Svaton M., Rejlova K., Zaliova M., Dobiasova A., Fiser K., Stuchly J.,
RA   Grega M., Rosova B., Zachoval R., Klezl P., Eis V., Kindlova E.,
RA   Buchler T., Trka J., Boublikova L.;
RT   "Molecular basis of cisplatin resistance in testicular germ cell
RT   tumors.";
RL   Cancers (Basel) 11:1316.1-1316.18(2019).
//